MISCELLANEOUS DESIGN

Trademark usage description

pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, Read More

Vienna Information

26 . 4 . 2

RectanglesRectangles

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 4 . 6

Quadrilateral figures with one or more convex or concave sides -- Note: Not including elongated surfaces with one or more convex or concave sides (25.3.1).Figures quadrilatérales à un ou plusieurs côtés convexes ou concaves -- Note: Non compris les surfaces allongées avec un ou plusieurs côtés convexes ou concaves (25.3.1).

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines

Classification kind code

Mark Details

Serial Number

2058420

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 5 on 14^th Aug 2023	Withdrawn by Owner
Submitted for opposition 287 on 19^th May 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 19^th Oct 2020	Filed
Submitted for opposition 1 on 19^th Oct 2020	Created
Submitted for opposition 31 on 19^th Oct 2020	Formalized